(Q43678470)

25 November 2017

Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone (English)

1 reference

25 November 2017

2

1 reference

25 November 2017

Hutzler JM

1

1 reference

25 November 2017

Korzekwa KR

3

1 reference

25 November 2017

Branch RA

4

1 reference

25 November 2017

Huang SM

5

1 reference

25 November 2017

Tracy TS

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

European Journal of Pharmaceutical Sciences

25 November 2017

1 reference

25 November 2017

14

1 reference

25 November 2017

47-52

1 reference

25 November 2017

1

1 reference

The polymorphic acetylation of dapsone in man

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Biochemistry and molecular biology of the human CYP2C subfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Sensitive and specific high-performance liquid chromatographic assay for 4'-hydroxyflurbiprofen and flurbiprofen in human urine and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Stereoselective disposition of flurbiprofen in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

High-performance liquid chromatographic analysis of the enantiomers of flurbiprofen and its metabolites in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

The disposition of dapsone in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Nonspecific binding of drugs to human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

The Disposition and Metabolism of Flurbiprofen in Several Species Including Man

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Role of cytochrome P450 2C9 and an allelic variant in the 4'-hydroxylation of (R)- and (S)-flurbiprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

Clinical pharmacokinetics of dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900144-0

7 January 2021

10.1016/S0928-0987(01)00144-0

Identifiers

DOI

1 reference

25 November 2017

1 reference